Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone versus lidocaine added to irrigation fluid for pain after transurethral ureterolithotripsy
IRCT20260723070324N1Phase 4Recruiting
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dexamethasone and lidocaine in ureterolithiasis (3 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Aug 2026; status: recruiting.
02
Drugs
dexamethasonelidocaine
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on IRCT20260723070324N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260723070324N1.